Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEPHRO Trial: NAC for CIN in Cirrhosis
NCT03759158Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in contrast-induced nephropathy (CIN) comparing NAC Arm with Placebo (2 arms). Primary endpoint: Development Of Contrast-Induced Nephropathy at Day 2. Started Dec 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT03759158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03759158.